Company Profiles

driven by the PitchBook Platform

AlloMek Therapeutics

Description

Developer of targeted therapies for rare diseases and cancer. Developer of targeted therapies for rare diseases and cancer. The company focuses on laminopathies, including LMNA, associated dilated cardiomyopathy and congenital muscular dystrophy (CMD). The company offers an allosteric, macrocyclic MEK kinase inhibitor program.

2010

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$875k

Latest Deal Amount

$1.3M

Total Amount Raised

3

Investors

Description

Developer of targeted therapies for rare diseases and cancer. Developer of targeted therapies for rare diseases and cancer. The company focuses on laminopathies, including LMNA, associated dilated cardiomyopathy and congenital muscular dystrophy (CMD). The company offers an allosteric, macrocyclic MEK kinase inhibitor program.

Website:

www.allomek.com

Formerly Known As

AlloStem Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

400 Farmington Avenue Farmington, CT 06032United States +1 (203) 208-2811
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AlloMek Therapeutics's full profile, request a free trial.

AlloMek Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AlloMek Therapeutics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Connecticut InnovationsVenture CapitalMinority000 0000000 0000
Fundación Andrés MarcioNot-For-Profit Venture CapitalMinority000 0000000 0000
Robert WolfeAngel (individual)Minority000 0000000 0000
Connecticut Innovations Venture Capital
Fundación Andrés Marcio Not-For-Profit Venture Capital
Robert Wolfe Angel (individual)

AlloMek Therapeutics Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Uday Khire Ph.DCo-Founder, Chief Executive Officer & Board Member
Barry Hart Ph.DCo-Founder, Project Manager and Director, Business Development
Uday Khire Ph.D Co-Founder, Chief Executive Officer & Board Member
Barry Hart Ph.D Co-Founder, Project Manager and Director, Business Development

AlloMek Therapeutics Board Members (2)

NameRepresentingRoleSinceContact
Info
Daniel WagnerConnecticut InnovationsManaging Director, Investments000 0000
Uday Khire Ph.DAlloMek TherapeuticsCo-Founder, Chief Executive Officer & Board Member000 0000
Daniel Wagner Managing Director, Investments Connecticut Innovations
Uday Khire Ph.D Co-Founder, Chief Executive Officer & Board Member AlloMek Therapeutics
Request full access to PitchBook